Therefore, it is speculated that a decrease in the activity of the tPA/plasminogen system that is due to a negative effect of plasminogen activator inhibitors may lead to insufficient production of mature BDNF, resulting in the impaired neural plasticity seen in the case of depression [62]. The gene discussed is BDNF; the disease is depressive disorder.